Showing results (2641-2650 of 6,778) with videos related to
Sort By:
Pageof 678
Clinical Therapeutics|March 1, 1994
Assessing health-related quality of life in chronic hepatitis C using the Sickness Impact ProfileG L Davis, L A Balart, E R Schiff, et al.Clinical Therapeutics|November 1, 1993
Diabetes control in the elderly: a randomized, comparative study of glyburide versus glipizide in non-insulin-dependent diabetes mellitusJ Rosenstock, P J Corrao, R B Goldberg, et al.Clinical Therapeutics|November 1, 1993
Treatment of disseminated intravascular coagulation with gabexate mesilateS Tamaki, H Wada, K Hiyoyama, et al.Clinical Therapeutics|November 1, 1993
Improving efficiencies in pharmaceutical distribution channels using the economic order quantity modelD L Sullivan, J C SchommerClinical Therapeutics|November 1, 1993
Comparative taste evaluation of aerosolized formulations of triamcinolone acetonide, flunisolide, and flunisolide with mentholW S Silvers, R Cohen, G D'Alonzo, et al.Clinical Therapeutics|November 1, 1993
Cimetidine QID and BID in rapid heartburn relief and healing of lesions in gastroesophageal reflux diseaseR H Palmer, D M Miller, D A Hedrich, et al.Clinical Therapeutics|November 20, 2009
Comparison of insulin detemir and insulin glargine in a basal-bolus regimen, with insulin aspart as the mealtime insulin, in patients with type 1 diabetes: a 52-week, multinational, randomized, open-label, parallel-group, treat-to-target noninferiority trialSimon Heller, Christoph Koenen, Bruce BodeClinical Therapeutics|November 20, 2009
Efficacy of a single dose of live attenuated influenza vaccine in previously unvaccinated children: a post hoc analysis of three studies of children aged 2 to 6 yearsStan L Block, Seth L Toback, Tingting Yi, et al.Clinical Therapeutics|November 20, 2009
Pharmacokinetics and tolerability of single escalating doses of fampridine sustained-release tablets in patients with multiple sclerosis: a Phase I-II, open-label trialTimothy Vollmer, Herbert R HenneyClinical Therapeutics|November 20, 2009
Steady-state pharmacokinetics and tolerability of orally administered fampridine sustained-release 10-mg tablets in patients with multiple sclerosis: a 2-week, open-label, follow-up studyTimothy Vollmer, Andrew R Blight, Herbert R HenneyPageof 678